Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degenerati Clinical Trials

Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD

Explore clinical trials studying Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD trial results

Completed

Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre)

NCT01972789

Conditions: Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD
Locations: Novartis Investigative Site Albury, New South Wales, Australia

Novartis Investigative Site Chatswood, New South Wales, Australia

Novartis Investigative Site Eastwood, New South Wales, Australia

Novartis Investigative Site Hurtsville, New South Wales, Australia

View all 16 locations

View Trial Details